If you have been managing POTS for any length of time, you have heard the standard advice: drink more fluids, increase your salt intake, and gradually build up exercise tolerance. For many patients, these three pillars genuinely move the needle. Symptoms become more manageable. Functional capacity improves. Life gets a little more predictable.
But for a significant portion of POTS patients, following this advice faithfully for months yields disappointing results. The dizziness persists. The heart rate spikes continue. The fatigue does not lift the way it was supposed to. And the frustration of doing everything right and still not improving is its own kind of difficulty.
This is not a failure of effort or willpower. It is a signal that something else is going on underneath the surface — something that fluids, salt, and exercise alone cannot reach.
Why the Standard Approach Works for Some and Not Others
POTS is not a single uniform condition. It is a syndrome, meaning it describes a pattern of symptoms rather than one specific disease process. The same outward presentation — a heart rate increase of 30 or more beats per minute upon standing, combined with characteristic symptoms — can stem from several different underlying mechanisms.
Fluids and salt work by increasing blood volume, which helps the cardiovascular system compensate for the pooling that happens when a person stands upright. Exercise, particularly recumbent exercise that avoids upright stress, builds cardiovascular conditioning and improves the efficiency of blood return to the heart. These approaches address the volume and conditioning components of POTS.
When those are the primary drivers of a patient’s symptoms, improvement often follows. When they are not, the same interventions produce little benefit — not because they are wrong, but because they are incomplete for that individual.
POTS Subtypes That Respond Differently
One of the most important things a POTS specialist evaluates is which subtype a patient likely has. According to select research, POTS can be broadly categorized into several subtypes, and each has different primary mechanisms and treatment implications.
Hyperadrenergic POTS is characterized by abnormally elevated norepinephrine levels upon standing. According to preliminary studies, patients with this subtype often experience a paradoxical rise in blood pressure rather than the typical drop, along with severe palpitations, trembling, anxiety-like symptoms, and headaches. Standard fluid and salt loading provides limited benefit for hyperadrenergic POTS patients because the core problem is not low blood volume — it is an overactive sympathetic nervous system that standard volume-expanding strategies cannot calm.
Neuropathic POTS involves partial autonomic neuropathy, where the small nerve fibers responsible for constricting blood vessels in the legs fail to function properly. Blood pools excessively upon standing because the reflex that should constrict those vessels is impaired. Physical deconditioning strategies help to a degree, but addressing the underlying neuropathic process requires a different treatment approach.
Some POTS patients have underlying hypervolemia or blood pooling in the splanchnic circulation that is not addressed by standard sodium supplementation. For these individuals, a different combination of medications and interventions may be necessary, as directed by a POTS specialist.
When Underlying Conditions Are Driving the Problem
Many patients who do not improve with basic POTS management have an underlying condition that is maintaining or worsening their autonomic dysfunction. Identifying and addressing that condition is what finally allows real progress.
Ehlers-Danlos Syndrome (EDS), particularly the hypermobile subtype, is one of the most common comorbidities seen in POTS patients. The abnormal collagen in EDS leads to excessive blood vessel laxity, which directly worsens orthostatic blood pooling. No amount of hydration compensates for structurally compliant vessels. Patients with EDS-related POTS often need joint stabilization, targeted physical therapy, and compression strategies tailored to their connective tissue needs.
Mast Cell Activation Syndrome (MCAS) is another frequently overlapping condition. Mast cells release mediators that directly affect blood vessel tone and heart rate, compounding autonomic instability in ways that are not responsive to standard POTS interventions. Patients with MCAS often find that identifying and managing their mast cell triggers significantly improves their POTS symptoms. Addressing both conditions simultaneously requires a dysautonomia specialist with experience managing this overlap.
Autoimmune POTS is increasingly recognized as a subtype in which autoantibodies target receptors in the autonomic nervous system. According to preliminary studies, a subset of POTS patients have antibodies against adrenergic and muscarinic receptors that directly disrupt autonomic regulation. For these patients, the underlying autoimmune process needs to be addressed, and standard POTS management provides only partial relief at best.
Long COVID has also become a common trigger for new-onset POTS that may not respond typically to standard management, particularly when neurological involvement or ongoing immune activation is contributing to symptoms.
The Exercise Paradox in POTS
Exercise is genuinely beneficial for many POTS patients, but it is also one of the most commonly misapplied recommendations. Standard exercise guidance does not account for the post-exertional malaise that many POTS patients experience, particularly those with overlapping conditions.
Pushing through exercise intolerance in a patient who has not yet achieved basic symptom stability often backfires. Heart rate dysregulation during exercise triggers a cascade of symptoms that can take days to recover from, gradually depleting a patient’s capacity rather than building it. A specialist who understands POTS exercise physiology will design a carefully structured reconditioning program that starts below the threshold where symptoms are triggered and progresses at a pace the patient’s autonomic system can actually tolerate.
For patients with significant deconditioning, pool-based exercise or recumbent cycling are typically recommended as starting points because they minimize the orthostatic challenge while still building cardiovascular capacity.
When Standard Management Needs to Go Further
This table outlines common reasons why standard POTS management may be insufficient and what additional evaluation typically looks like.
Reason Standard Management Fails | What This Might Mean | Next Step |
|---|---|---|
Symptoms unchanged after 3+ months of consistent effort | Possible unidentified subtype or underlying condition | Comprehensive autonomic evaluation with a POTS specialist |
Blood pressure rises rather than drops on standing | May indicate hyperadrenergic POTS | Norepinephrine testing and subtype-specific medication review |
Widespread joint pain and hypermobility alongside POTS | Possible Ehlers-Danlos Syndrome overlap | Connective tissue evaluation and integrated treatment plan |
Food sensitivities, flushing, or hives alongside POTS | Possible Mast Cell Activation Syndrome | MCAS-specific workup and treatment integration |
POTS onset following COVID-19 infection | Post-COVID autonomic dysfunction | Evaluation for neurological and immune components |
Medication Gaps in Standard Management
Many POTS patients receive a basic recommendation to try fludrocortisone or a beta blocker and are told to come back if things do not improve. These medications help some patients significantly, but there is a wide range of medications used in POTS management, many of which are used off-label and require careful selection based on the patient’s specific subtype and clinical profile. These decisions should always be made under specialist supervision.
For hyperadrenergic POTS, medications that reduce sympathetic output are often far more helpful than volume-expanding agents. For neuropathic POTS, agents that support peripheral vasoconstriction may be more relevant. For patients with MCAS overlap, antihistamines and mast cell stabilizers are sometimes the intervention that finally produces meaningful autonomic improvement.
A POTS specialist in Maryland who takes the time to understand a patient’s complete clinical picture — including their subtype, comorbidities, and response history — is in the best position to recommend medications that actually match the underlying problem.
What a Proper Evaluation Should Look For
If you have been managing POTS with standard recommendations for several months and are not seeing meaningful improvement, the next step is a more thorough evaluation rather than simply pushing harder on the same interventions.
A comprehensive POTS evaluation reviews orthostatic vitals in detail, considers autonomic testing if clinically indicated, screens for overlapping conditions such as EDS and MCAS, takes a complete medication and supplement history, evaluates dietary factors that may be contributing, and considers whether any infectious, autoimmune, or structural factors may be sustaining the dysautonomia.
At Diekman Dysautonomia, Dr. Diekman takes exactly this kind of individualized approach. Telemedicine appointments are available for patients in Maryland, Illinois, Georgia, Nevada, and Missouri. If you have been doing everything right and still struggling, a specialist evaluation may reveal exactly what has been missing from your treatment plan. Contact the office at 833-768-7633 to schedule your appointment.
